IDiyas

For the Inventor, By the Inventor

Needham, MA, United States of America

Chester A Metcalf, Iii

USPTO Granted Patents = 34 


Average Co-Inventor Count = 6.6

ph-index = 9

Forward Citations = 190(Granted Patents)


Location History:

  • Boston, MA (US) (2003 - 2006)
  • Needham, MA (US) (2004 - 2016)

Company Filing History:

goldMedal20 out of 69 
 
Ariad Pharmaceuticals, Inc.
 patents
silverMedal11 out of 59 
 
Cubist Pharmaceuticals, Incorporated
 patents
bronzeMedal1 out of 13 
 
Ariad Gene Therapeutics, Inc.
 patents
4. 1 out of 2,405 
 
Merck Sharp + Dohme Corp.
 patents
5. 1 out of 1 
 
Araid Gene Therapeutics, Inc.
 patent

Years Active: 2003-2016

where 'Filed Patents' based on already Granted Patents

34 patents (USPTO):
1. 9394308 - Inhibiting the transient receptor potential A1 ion channel (2016-07-19),
2. 9278971 - Substituted acetylenic pyrazolo[1,5-a]pyrimidines as kinase inhibitors (2016-03-08),
3. 9193729 - Inhibiting transient receptor potential ion channel TRPA1 (2015-11-24),
4. 9108966 - Beta-lactamase inhibitors (2015-08-18),
5. 9090561 - Acetylenic heteroaryl compounds (2015-07-28),
6. 9029533 - Substituted acetylenic imidazo[1,2-A]pyridazines as kinase inhibitors (2015-05-12),
7. 9024014 - Phosphorus-containing compounds and uses thereof (2015-05-05),
8. 8969570 - Beta-lactamase inhibitors (2015-03-03),
9. 8962844 - 1,3,4-oxadiazole and 1,3,4-thiadiazole β-lactamase inhibitors (2015-02-24),
10. 8962843 - 1,3,4-oxadiazole and 1,3,4-thiadiazole beta-lactamase inhibitors (2015-02-24),
11. 8940897 - 1,3,4-oxadiazole and 1,3,4-thiadiazole β-lactamase inhibitors (2015-01-27),
12. 8933233 - 1,3,4-oxadiazole and 1,3,4-thiadiazole β-lactamase inhibitors (2015-01-13),
13. 8933232 - 1,3,4-oxadiazole and 1,3,4-thiadiazole beta-lactamase inhibitors (2015-01-13),
14. 8927724 - Isoxazole beta-lactamase inhibitors (2015-01-06),
15. 8916709 - 1,2,4-oxadiazole and 1,2,4-thiadiazole β-lactamase inhibitors (2014-12-23),

Title: Chester A Metcalf, III: Pioneering Inventor Pushing Boundaries of Innovation

Introduction: Chester A Metcalf, III, a renowned inventor based in Needham, MA, is globally celebrated for his inventive creations that continuously inspire the world. With a total of 34 patents to his name, Metcalf's relentless pursuit of innovation and excellence has enabled him to push the boundaries of what is possible in the field of inventions.

Latest Patents: Metcalf's latest patents include groundbreaking inventions such as "Inhibiting the transient receptor potential A1 ion channel" and "Substituted acetylenic pyrazolo[1,5-a]pyrimidines as kinase inhibitors." The former focuses on novel compounds and pharmaceutical compositions for inhibiting the TRPA1 ion channel, addressing medical conditions related to TRPA1 like pain and respiratory ailments.

Career Highlights: Throughout his illustrious career, Metcalf has made significant contributions to the field of inventions. He has worked with reputable companies such as Ariad Pharmaceuticals, Inc. and Cubist Pharmaceuticals, Incorporated, where his innovative spirit and vision have led to the development of groundbreaking technologies.

Collaborations: Metcalf's collaborations with esteemed coworkers Yihan Wang and William C Shakespeare have further enhanced his innovative pursuits. Together, they have brought a wealth of expertise and creativity to the table, resulting in successful inventions and patents that have revolutionized the industry.

Conclusion: In conclusion, Chester A Metcalf, III stands as a beacon of inspiration in the world of innovation and inventions. His pioneering spirit, coupled with his unwavering dedication to pushing the boundaries of what is possible, continues to leave a lasting impact on the industry and inspire generations of inventors to come.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…